Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
75.5M
-
Number of holders
-
11
-
Total 13F shares, excl. options
-
1.99M
-
Shares change
-
+1.74M
-
Total reported value, excl. options
-
$4.33M
-
Value change
-
+$3.79M
-
Number of buys
-
5
-
Number of sells
-
-2
-
Price
-
$2.18
Significant Holders of Cellectar Biosciences, Inc. - Common Stock, $0.00001 par value per share (CLRB) as of Q2 2019
12 filings reported holding CLRB - Cellectar Biosciences, Inc. - Common Stock, $0.00001 par value per share as of Q2 2019.
Cellectar Biosciences, Inc. - Common Stock, $0.00001 par value per share (CLRB) has 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.99M shares
of 75.5M outstanding shares and own 2.63% of the company stock.
Largest 10 shareholders include BOXER CAPITAL, LLC (920K shares), TANG CAPITAL MANAGEMENT LLC (680K shares), RENAISSANCE TECHNOLOGIES LLC (123K shares), CVI Holdings, LLC (106K shares), SPHERA FUNDS MANAGEMENT LTD. (87.5K shares), MORGAN STANLEY (35.2K shares), VANGUARD GROUP INC (16.8K shares), DIMENSIONAL FUND ADVISORS LP (10.3K shares), LADENBURG THALMANN FINANCIAL SERVICES INC. (4K shares), and US BANCORP \DE\ (2.86K shares).
This table shows the top 11 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.